Latest News

  • Alkermes Announces Initiation of Study 217 for ALKS 5461 for Treatment of Major Depressive Disorder Read More
  • Alkermes to Present at Goldman Sachs 38th Annual Global Healthcare Conference Read More
  • Alkermes Announces Initiation of Phase 3 Study of ALKS 3831 in Young Adult Patients Read More


Learn more Learn More Alkermes PLC Investor Relations

Working at Alkermes

Join Our Team Join Our Team Working at Alkermes